Pub. Date : 2015
PMID : 26134919
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Although the impressive clinical activity of new hormonal agents, such as the second-generation AR antagonist enzalutamide (formerly MDV3100) and the selective inhibitor of cytochrome P450 17A1 (CYP17A1) abiraterone acetate (AA), in patients with metastatic castration-resistant prostate cancer (mCRPC), innate or acquired resistance invariably arises. | Abiraterone Acetate | cytochrome P450 family 17 subfamily A member 1 | Homo sapiens |
2 | Although the impressive clinical activity of new hormonal agents, such as the second-generation AR antagonist enzalutamide (formerly MDV3100) and the selective inhibitor of cytochrome P450 17A1 (CYP17A1) abiraterone acetate (AA), in patients with metastatic castration-resistant prostate cancer (mCRPC), innate or acquired resistance invariably arises. | Abiraterone Acetate | cytochrome P450 family 17 subfamily A member 1 | Homo sapiens |